BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 38671227)

  • 1. Dysregulation of TCONS_00006091 contributes to the elevated risk of oral squamous cell carcinoma by upregulating SNAI1, IRS and HMGA2.
    Ma D; Chen J; Shi Y; Gao H; Wei Z; Fan J; Wang L
    Sci Rep; 2024 Apr; 14(1):9616. PubMed ID: 38671227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential involvement of miR-375 in the premalignant progression of oral squamous cell carcinoma mediated via transcription factor KLF5.
    Shi W; Yang J; Li S; Shan X; Liu X; Hua H; Zhao C; Feng Z; Cai Z; Zhang L; Zhou D
    Oncotarget; 2015 Nov; 6(37):40172-85. PubMed ID: 26474386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMGA1 and HMGA2 expression and comparative analyses of HMGA2, Lin28 and let-7 miRNAs in oral squamous cell carcinoma.
    Sterenczak KA; Eckardt A; Kampmann A; Willenbrock S; Eberle N; Länger F; Kleinschmidt S; Hewicker-Trautwein M; Kreipe H; Nolte I; Murua Escobar H; Gellrich NC
    BMC Cancer; 2014 Sep; 14():694. PubMed ID: 25245141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unveiling the Potential of Serum MiR-483-5p: A Promising Diagnostic and Prognostic Biomarker in OLP and OSCC Patients by
    Soltaninezhad P; Arab F; Mohtasham N; FakherBaheri M; Kavishahi NN; Aghaee-Bakhtiari SH; Zare-Mahmoodabadi R; Pakfetrat A; Taban KI; Mohajertehran F
    Curr Pharm Des; 2024; 30(4):310-322. PubMed ID: 38310566
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HMGA2 is down-regulated by microRNA let-7 and associated with epithelial-mesenchymal transition in oesophageal squamous cell carcinomas of Kazakhs.
    Liu Q; Liu T; Zheng S; Gao X; Lu M; Sheyhidin I; Lu X
    Histopathology; 2014 Sep; 65(3):408-17. PubMed ID: 24612219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic changes during malignant transformation in primary cells of oral lichen planus: Succinate accumulation and tumour suppression.
    Yang Q; Sun H; Wang X; Yu X; Zhang J; Guo B; Hexige S
    J Cell Mol Med; 2020 Jan; 24(2):1179-1188. PubMed ID: 31793175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of miRNA-27b-3p suppresses keratinocytes apoptosis in oral lichen planus.
    Chen J; Wang Y; Du G; Zhang W; Cao T; Shi L; Wang Y; Mi J; Tang G
    J Cell Mol Med; 2019 Jun; 23(6):4326-4337. PubMed ID: 30973209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-150 suppressed cell viability, invasion and EMT via HMGA2 in oral squamous cell carcinoma.
    Liu DK; Yu S; Li JP; Song WW; Li JH
    Eur Rev Med Pharmacol Sci; 2021 Jun; 25(11):3981-3989. PubMed ID: 34156675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
    Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
    Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LncRNA DANCR regulates the growth and metastasis of oral squamous cell carcinoma cells via altering miR-216a-5p expression.
    Qu XH; Shi YL; Ma Y; Bao WW; Yang L; Li JC; Zhang F
    Hum Cell; 2020 Oct; 33(4):1281-1293. PubMed ID: 32860589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of MAPK and its regulatory miRNAs (603, 4301, 8485, and 4731) with the malignant transformation of oral lichen planus.
    Gholizadeh N; Emami Razavi A; Mohammadpour H; Tavakol F; Sheykhbahaei N
    Mol Biol Rep; 2020 Feb; 47(2):1223-1232. PubMed ID: 31828562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression.
    Wang X; Li H; Shi J
    Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-92a regulates oral squamous cell carcinoma (OSCC) cell growth by targeting FOXP1 expression.
    Guo J; Wen N; Yang S; Guan X; Cang S
    Biomed Pharmacother; 2018 Aug; 104():77-86. PubMed ID: 29772443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma.
    Luo C; Zhang J; Zhang Y; Zhang X; Chen Y; Fan W
    Cell Cycle; 2020 Aug; 19(15):1983-1993. PubMed ID: 32594835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA SNHG20 regulates cell migration, invasion, and proliferation via the microRNA-19b-3p/RAB14 axis in oral squamous cell carcinoma.
    Zhu X; Zhang H; Xu J
    Bioengineered; 2021 Dec; 12(1):3993-4003. PubMed ID: 34282711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.
    Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y
    FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-16 functions as a tumor-suppressor gene in oral squamous cell carcinoma by targeting AKT3 and BCL2L2.
    Wang X; Li GH
    J Cell Physiol; 2018 Dec; 233(12):9447-9457. PubMed ID: 30136280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral squamous cell carcinoma: microRNA expression profiling and integrative analyses for elucidation of tumourigenesis mechanism.
    Manikandan M; Deva Magendhra Rao AK; Arunkumar G; Manickavasagam M; Rajkumar KS; Rajaraman R; Munirajan AK
    Mol Cancer; 2016 Apr; 15():28. PubMed ID: 27056547
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD133 expression in oral lichen planus correlated with the risk for progression to oral squamous cell carcinoma.
    Sun L; Feng J; Ma L; Liu W; Zhou Z
    Ann Diagn Pathol; 2013 Dec; 17(6):486-9. PubMed ID: 23911820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long noncoding RNA UCA1 promotes cell growth, migration, and invasion by targeting miR-143-3p in oral squamous cell carcinoma.
    Duan Q; Xu M; Wu M; Zhang X; Gan M; Jiang H
    Cancer Med; 2020 May; 9(9):3115-3129. PubMed ID: 32130788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.